Insider filing · BGNE

John Oyler sold $3.6M of BeiGene (BGNE)

Executed Oct 8 2024, disclosed Oct 10 2024, 2 days later.

Returns are measured on stock purchases only.

JO John Oyler Chief Executive Officer profile →

John Oyler (Chief Executive Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in BeOne Medicines AG (ONC). The largest single filing was $89.3M of ONC (282,921 sh across 16 lots, as filed), executed Jul 15.

BGNE BGNE BGNE · 23 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→